Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Lifecore Biomedical (LFCR) Equity Ratio: 2011-2025

Historic Equity Ratio for Lifecore Biomedical (LFCR) over the last 15 years, with May 2025 value amounting to 0.01.

  • Lifecore Biomedical's Equity Ratio fell 87.47% to 0.01 in Q2 2025 from the same period last year, while for May 2025 it was 0.01, marking a year-over-year decrease of 87.47%. This contributed to the annual value of 0.01 for FY2025, which is 87.47% down from last year.
  • According to the latest figures from FY2025, Lifecore Biomedical's Equity Ratio is 0.01, which was down 87.47% from 0.04 recorded in FY2024.
  • In the past 5 years, Lifecore Biomedical's Equity Ratio registered a high of 0.40 during FY2021, and its lowest value of -0.02 during FY2023.
  • Over the past 3 years, Lifecore Biomedical's median Equity Ratio value was 0.01 (recorded in 2025), while the average stood at 0.01.
  • In the last 5 years, Lifecore Biomedical's Equity Ratio crashed by 105.22% in 2023 and then soared by 367.06% in 2024.
  • Lifecore Biomedical's Equity Ratio (Yearly) stood at 0.40 in 2021, then declined by 20.55% to 0.32 in 2022, then plummeted by 105.22% to -0.02 in 2023, then soared by 367.06% to 0.04 in 2024, then plummeted by 87.47% to 0.01 in 2025.